Pharmanutra S.p.A.

Milan Stock Exchange:PHN.MI

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🏬 Consumer Packaged Goods

💊 Drugstores & Retail Pharmacies

🛍 Retail & Wholesale

🛍 Specialty Retail

Location

Italy

Market Cap

USD 513.19 M

Share Price

USD 53.05

Avg Daily Volume

9,931

Change (1 day)

-1.37%

Change (1 year)

4.48%

Change (YTD)

-6.28%

Pharmanutra S.p.A. Share Price Year-To-Date (YTD) return on June 20, 2025: -6.28%

Pharmanutra S.p.A. Share Price Year-To-Date (YTD) return is -6.28% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

Pharmanutra S.p.A. 52-week low Share Price is USD 66.65 on June 20, 2025, which is 25.63% above the current Share Price.
Pharmanutra S.p.A. 52-week low Share Price is USD 49.78 on June 20, 2025, which is -6.17% below the current Share Price.
Pharmanutra S.p.A. average Share Price for the last 52 weeks is USD 56.88.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	118
Sector	🏥 Health Care
Industries Pharmaceuticals 🏬 Consumer Packaged Goods 💊 Drugstores & Retail Pharmacies 🛍 Retail & Wholesale 🛍 Specialty Retail

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.